Prolonged disease control with local treatments in oligo-acquired resistance to immune-checkpoint inhibitors

Transl Lung Cancer Res. 2023 Jun 30;12(6):1332-1334. doi: 10.21037/tlcr-23-50. Epub 2023 May 15.

Authors

Hugo Arasanz^{1

2}, Idoia Morilla¹, Maite Martínez-Aguillo¹, Lucía Teijeira¹, Ruth Vera^{1

2}, Maria Alsina^{1

2}

Affiliations

¹ Department of Medical Oncology, Hospital Universitario de Navarra, Navarra Medical Research Institute (IdiSNA), Pamplona, Spain.
² Oncobiona Group, Navarrabiomed, Navarra Medical Research Institute (IdiSNA), Pamplona, Spain.

No abstract available

Keywords: Lung cancer; immune-checkpoint; local; oligo-acquired resistance; programmed cell death 1 (PD-1).

Publication types

Editorial
Comment